These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38953323)

  • 21. Pseudomonas aeruginosa bloodstream infections in children and adolescents: risk factors associated with carbapenem resistance and mortality.
    Rodríguez NEG; Aguilera-Alonso D; Escosa L; Gómez-Gil MR; Manzanares Á; Ascaso MG; Bermejo-Gómez A; Abad MJG; Ramos AM; Núñez AS; Orellana MÁ; Cercenado E; Lozano JS; Calvo C; Baquero-Artigao F;
    J Hosp Infect; 2024 Jul; 149():56-64. PubMed ID: 38735628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of carbapenem resistance and receipt of active antimicrobial therapy on clinical outcomes of Acinetobacter baumannii bloodstream infections.
    Esterly JS; Griffith M; Qi C; Malczynski M; Postelnick MJ; Scheetz MH
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4844-9. PubMed ID: 21825287
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cefepime versus carbapenems for treatment of AmpC beta-lactamase-producing Enterobacterales bloodstream infections.
    Herrmann J; Burgener-Gasser AV; Goldenberger D; Roth J; Weisser M; Tamma PD; Tschudin-Sutter S
    Eur J Clin Microbiol Infect Dis; 2024 Feb; 43(2):213-221. PubMed ID: 37993680
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical impact of early detection of ESBL-producing Enterobacterales with PCR-based blood culture assays.
    Chang KM; Haghamad A; Saunders-Hao P; Shaffer A; Mirsaidi N; Zimilover A; Epstein M; Jain S; Streva V; Juretschko S; Demissie S; Gautam-Goyal P
    Am J Infect Control; 2024 Jan; 52(1):73-80. PubMed ID: 37544512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors and mortality for patients with Bloodstream infections of Klebsiella pneumoniae during 2014-2018: Clinical impact of carbapenem resistance in a large tertiary hospital of China.
    Chang H; Wei J; Zhou W; Yan X; Cao X; Zuo L; Chen S; Yao K; Huang R; Chen Y; Wu C
    J Infect Public Health; 2020 May; 13(5):784-790. PubMed ID: 31843651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
    Tamma PD; Han JH; Rock C; Harris AD; Lautenbach E; Hsu AJ; Avdic E; Cosgrove SE;
    Clin Infect Dis; 2015 May; 60(9):1319-25. PubMed ID: 25586681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A retrospective analysis of
    Shi Q; Huang C; Xiao T; Wu Z; Xiao Y
    Antimicrob Resist Infect Control; 2019; 8():68. PubMed ID: 31057792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and molecular characteristics and risk factors for patients acquiring carbapenemase-producing and non-carbapenemase-producing carbapenem-nonsusceptible-Enterobacterales bacteremia.
    Wu AY; Chang H; Wang NY; Sun FJ; Liu CP
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1229-1238. PubMed ID: 34824020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
    Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
    PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study.
    Giannella M; Pascale R; Pancaldi L; Monari C; Ianniruberto S; Malosso P; Bussini L; Bartoletti M; Tedeschi S; Ambretti S; Lewis R; Viale P
    Clin Microbiol Infect; 2020 Jul; 26(7):897-903. PubMed ID: 32006697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and Bacterial Risk Factors for Mortality in Children With Carbapenem-resistant Enterobacteriaceae Bloodstream Infections in India.
    Nabarro LEB; Shankar C; Pragasam AK; Mathew G; Jeyaseelan V; Veeraraghavan B; Verghese VP
    Pediatr Infect Dis J; 2017 Jun; 36(6):e161-e166. PubMed ID: 28005691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and Clinical Impact of Bloodstream Infection Caused by Carbapenemase-Producing Enterobacteriaceae in Seven Latin American Countries.
    Villegas MV; Pallares CJ; Escandón-Vargas K; Hernández-Gómez C; Correa A; Álvarez C; Rosso F; Matta L; Luna C; Zurita J; Mejía-Villatoro C; Rodríguez-Noriega E; Seas C; Cortesía M; Guzmán-Suárez A; Guzmán-Blanco M
    PLoS One; 2016; 11(4):e0154092. PubMed ID: 27104910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Chopra T; Marchaim D; Veltman J; Johnson P; Zhao JJ; Tansek R; Hatahet D; Chaudhry K; Pogue JM; Rahbar H; Chen TY; Truong T; Rodriguez V; Ellsworth J; Bernabela L; Bhargava A; Yousuf A; Alangaden G; Kaye KS
    Antimicrob Agents Chemother; 2012 Jul; 56(7):3936-42. PubMed ID: 22547616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of elderly patients with bloodstream infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae in an Italian Internal Medicine ward.
    Meini S; Laureano R; Tascini C; Arena F; Fani L; Frullini A; Passaleva MT; Roberts AT; Mannini D; Sbrana F; Ripoli A; Rossolini GM
    Eur J Intern Med; 2018 Feb; 48():50-56. PubMed ID: 29089174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the introduction of an automated microbiologic system on the clinical outcomes of bloodstream infections caused by Enterobacteriaceae strains.
    Callefi LA; Medeiros EA; Furtado GH
    Rev Soc Bras Med Trop; 2013; 46(1):45-9. PubMed ID: 23563824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
    Satlin MJ; Cohen N; Ma KC; Gedrimaite Z; Soave R; Askin G; Chen L; Kreiswirth BN; Walsh TJ; Seo SK
    J Infect; 2016 Oct; 73(4):336-45. PubMed ID: 27404978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical impacts of the rapid diagnostic method on positive blood cultures.
    Tsai YW; Zhang B; Chou HY; Chen HJ; Hsu YC; Shiue YL
    Lab Med; 2024 Mar; 55(2):179-184. PubMed ID: 37352545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
    Li JQ; Tang CQ; Wang H; Ji SZ; Lü KY; Xiao SC; Deng AM; Huang Y; Xia ZF
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1903-6. PubMed ID: 27373357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seven-day antibiotic therapy for Enterobacterales bacteremia in high-risk neutropenic patients: toward a new paradigm.
    Herrera F; Torres D; Laborde A; Jordán R; Tula L; Mañez N; Pereyra ML; Suchowiercha N; Berruezo L; Gudiol C; Ibáñez MLG; Eusebio MJ; Lambert S; Barcán L; Rossi IR; Nicola F; Pennini M; Monge R; Blanco M; Visús M; Reynaldi M; Carbone R; Pasterán F; Corso A; Rapoport M; Carena AA;
    Eur J Clin Microbiol Infect Dis; 2024 Sep; 43(9):1741-1751. PubMed ID: 38958809
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors, outcomes and genotypes of carbapenem-nonsusceptible Klebsiella pneumoniae bloodstream infection: a three-year retrospective study in a large tertiary hospital in Northern China.
    Zheng SH; Cao SJ; Xu H; Feng D; Wan LP; Wang GJ; Xiao XG
    Infect Dis (Lond); 2018 Jun; 50(6):443-451. PubMed ID: 29303020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.